Survival Benefit For Vinorelbine-Cisplatin In NSCLC Patient, Phase III Trial Finds
NCI Phase II Trial Tests Vaccine Plus Hormone Therapy For Recurrent Prostate Cancer
Two-Point Rise In PSA Signals High-Risk Prostate Cancer
High Cervical Cancer Rates Indicate Access Problems
Lifestyle Changes Common After Cancer Diagnosis
Proton Beam Radiation Helps Cancer Patients Retain Vision
Cooperative Group Trials Approved By NCI Are Listed
Trending Stories
- Richard Pazdur left FDA to avoid being part of “the destruction of the American medical system”
- In first NCAB director’s report, Anthony Letai focuses on centralized grant review, budget outlook
- Pazdur leaves FDA after 25-year career that shaped the agency’s oncology regulations
BIO calls for the end of “constant turmoil,” urges the administration to “right the ship” - Pediatric cancer five-year survival rate has increased dramatically, AACR says in inaugural Pediatric Cancer Progress Report
- Anthony Letai pledges to ensure stability for extramural and intramural cancer science
- Antonio Wolff, Mikala Egeblad named co-directors of Johns Hopkins Kimmel Cancer Center Breast and Gynecologic Cancer Program









